Measurement of precursor miRNA in exosomes from human ESC-derived mesenchymal stem cells

Methods in Molecular Biology

Volumn 1024, Issue , 2013, Pages 69-86

  Chen, Tian Sheng ^a   Lim, Sai Kiang ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

Author keywords

Exosome; Measurement; Mesenchymal stem cell; miRNA; Precursor miRNA; Quantification

Indexed keywords

AGAROSE; MICRORNA; NUCLEIC ACID; RIBONUCLEASE III; RNA DIRECTED DNA POLYMERASE; CULTURE MEDIUM; ESCHERICHIA COLI PROTEIN; RIBONUCLEASE III, E COLI; RNA PRECURSOR;

ARTICLE; CELL FRACTIONATION; CELL ISOLATION; ELECTROPHORESIS; EMBRYONIC STEM CELL; EXOSOME; FLUORESCENCE; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIMIT OF QUANTITATION; LIPID COMPOSITION; MEASUREMENT; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; MICROPLATE READER; MOLECULAR WEIGHT; PRECURSOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; AGAR GEL ELECTROPHORESIS; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DNA MICROARRAY; GENETICS; ISOLATION AND PURIFICATION; MESENCHYMAL STROMA CELL; METABOLISM; RNA TRANSPORT; ULTRACENTRIFUGATION;

CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ELECTROPHORESIS, AGAR GEL; EMBRYONIC STEM CELLS; ESCHERICHIA COLI PROTEINS; EXOSOMES; HUMANS; MESENCHYMAL STROMAL CELLS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RIBONUCLEASE III; RNA PRECURSORS; RNA TRANSPORT; ULTRACENTRIFUGATION;

EID: 84924841802     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-453-1_6     Document Type: Article

References (44)

1. Kern S, Eichler H, Stoeve J et al (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24(5): 1294-1301
2. Banas A, Teratani T, Yamamoto Y et al (2007) Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46(1):219-228
3. in 't Anker PS, Noort WA, Scherjon SA et al (2003) Mesenchymal stem cells in human second- trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88(8):845-852
4. Young HE, Steele TA, Bray RA et al (2001) Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 264(1): 51-62
5. Roubelakis MG, Pappa KI, Bitsika V et al (2007) Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: Comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 16(6):931-952
6. Fukuchi Y, Nakajima H, Sugiyama D et al (2004) Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 22(5):649-658
7. Miao Z, Jin J, Chen L et al (2006) Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 30(9): 681-687
8. Brooke G, Cook M, Blair C et al (2007) Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol 18(6): 846-858
9. Huang GTJ, Gronthos S, Shi S (2009) Critical reviews in oral biology & medicine: Mesenchymal stem cells derived from dental tissues vs. those from other sources: Their biology and role in Regenerative Medicine. J Dent Res 88(9):792-806
10. Andre F, Chaput N, Schartz NE et al (2004) Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol 172(4):2126-2136
11. Lian Q, Lye E, Suan Yeo K et al (2007) Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells 25(2):425-436
12. Lai RC, Arslan F, Tan SS et al (2010) Derivation and characterization of human fetal MSCs: An alternative cell source for large-scale production of cardioprotective microparticles. J Mol Cell Cardiol 48(6):1215-1224
13. Bernardo ME, Pagliara D, Locatelli F (2012) Mesenchymal stromal cell therapy: A revolution in Regenerative Medicine? Bone Marrow Transplant 47(2):164-171
14. Salem HK, Thiemermann C (2010) Mesenchymal stromal cells: Current understanding and clinical status. Stem Cells 28(3): 585-596
15. Ankrum J, Karp JM (2010) Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol Med 16(5):203-209
16. Hare JM, Traverse JH, Henry TD et al (2009) A Randomized, Double-Blind, Placebo- Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction. J Am Coll Cardiol 54(24): 2277-2286
17. Le Blanc K, Frassoni F, Ball L et al (2008) Mesenchymal stem cells for treatment of steroid- resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371(9624):1579-1586
18. Duijvestein M, Vos ACW, Roelofs H et al (2010) Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: Results of a phase I study. Gut 59(12):1662-1669
19. Wright KT, El Masri W, Osman A et al (2011) Concise review: Bone marrow for the treatment of spinal cord injury: Mechanisms and clinical applications. Stem Cells 29(2): 169-178
20. Bhansali A, Upreti V, Khandelwal N et al (2009) Ef ficacy of autologous bone marrowderived stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cells Dev 18(10):1407-1415
21. Iso Y, Spees JL, Serrano C et al (2007) Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 354(3):700-706
22. da Silva ML, Caplan AI, Nardi NB (2008) In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26(9):2287-2299
23. Dai W, Hale SL, Martin BJ et al (2005) Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: Shortand long-term effects. Circulation 112(2): 214-223
24. Noiseux N, Gnecchi M, Lopez-Ilasaca M et al (2006) Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 14(6):840-850
25. Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98(5):1076-1084
26. Gnecchi M, He H, Noiseux N et al (2006) Evidence supporting paracrine hypothesis for Akt-modi fied mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20(6):661-669
27. Timmers L, Lim S-K, Arslan F et al (2008) Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 1:129-137
28. Togel F, Hu Z, Weiss K et al (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289(1):F31-F42
29. Chen L, Tredget EE, Wu PY et al (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3(4):e1886
30. Arthur A, Zannettino A, Gronthos S (2009) The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol 218(2):237-245
31. Humphreys BD, Bonventre JV (2008) Mesenchymal stem cells in acute kidney injury. Annu Rev Med 59:311-325
32. Patel KM, Crisostomo P, Lahm T et al (2007) Mesenchymal stem cells attenuate hypoxic pulmonary vasoconstriction by a paracrine mechanism. J Surg Res 143(2):281-285
33. Lai RC, Arslan F, Lee MM et al (2010) Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4(3):214-222
34. Thery C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9(8):581-593
35. Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: Extracellular organelles important in intercellular communication. J Proteomics 73(10):1907-1920
36. Simpson RJ, Jensen SS, Lim JW (2008) Proteomic pro filing of exosomes: Current perspectives. Proteomics 8(19):4083-4099
37. Thery C, Duban L, Segura E et al (2002) Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol 3(12):1156-1162
38. Valadi H, Ekstrom K, Bossios A et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6): 654-659
39. Ma B, Ren J, Jiang HF et al (2008) Antitumor activities against hepatocellular carcinoma induced by bone marrow mesenchymal stem cells pulsed with tumor-derived exosomes. Beijing Da Xue Xue Bao 40(5):494-499
40. Smalheiser NR (2007) Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biol Direct 2:35
41. Chen TS, Lai RC, Lee MM et al (2010) Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 38(1):215-224
42. Lai RC, Choo A, Lim SK (2011) Derivation and characterization of human ESC-derived mesenchymal stem cells. Methods Mol Biol 698:141-150
43. Sze SK, de Kleijn DP, Lai RC et al (2007) Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics 6(10):1680-1689
44. Schmittgen TD, Jiang J, Liu Q et al (2004) A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res 32(4):e43